Entasis Therapeutics Inc.
CAGE Code: 7JD21
NCAGE Code: 7JD21
Status: Active
Type: Manufacturer
Summary
Entasis Therapeutics Inc. is an Active Manufacturer with the Cage Code 7JD21.
Address
35 Gatehouse Dr
Waltham MA 02451-1215
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Netcracker Technology Corporation Electronics Corp Of America Advanced Digital Systems Inc Artisan Industries, Inc. Microdealers Inc Raytheon Company Nuclear Instruments Dept Of Lfe Corp American Research Products Last Armor Coast To Coast Temporary Services Bosch Automotive Motor Systems Gtr Co Dome Imaging Systems Inc Black And Webster Inc Ceramem Separations Facia Reco Associates L P Hypnap Llc Laboratory Associates Inc Norman Associates, Inc. Kbm America
Frequently Asked Questions (FAQ) for CAGE 7JD21
- What is CAGE Code 7JD21?
- 7JD21 is the unique identifier used by NATO Organizations to reference the physical entity known as Entasis Therapeutics Inc. located at 35 Gatehouse Dr, Waltham MA 02451-1215, United States.
- Who is CAGE Code 7JD21?
- 7JD21 refers to Entasis Therapeutics Inc. located at 35 Gatehouse Dr, Waltham MA 02451-1215, United States.
- Where is CAGE Code 7JD21 Located?
- CAGE Code 7JD21 is located in Waltham, MA, USA.
Contracting History for CAGE 7JD21 Most Recent 25 Records
- 75N93020C00017
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- 19 Sep 2022
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,863,913.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00017
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- 29 Apr 2022
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,863,913.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00017
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- 21 Jul 2021
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,863,913.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00017
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- 13 Mar 2023
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,863,913.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00017
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- 9 Mar 2022
- To Identify And Develop A Non-Beta-Lactam Pbp Inhibitor (Nbp) With Broad Spectrum Of Activity Against Mdr Gram-Negative Eskape Pathogens.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $5,863,913.00
- Department Of Health And Human Services (Hhs)